Position in BSX
as of Jun 30, 2026
· filed Jul 23, 2026
Position Value
$2,902
-$6,442 QoQ
Shares Held
68
-30.6% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#1,402
of 1,468 holders
Holding Since
Dec 2023
7 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in BSX Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Jun 30, 2026Cape Investment Advisory, Inc. holds $1,930,623 across 13 Medical Devices names. BSX ranks #10 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | SYK |
Stryker Corp
|
2,490 | $783,951 | |
| 2 | DXCM |
Dexcom Inc
|
8,111 | $546,275 | |
| 3 | MDT |
Medtronic plc
|
5,074 | $396,938 | |
| 4 | ABT |
Abbott Laboratories
|
817 | $74,134 | |
| 5 | BIO |
Bio-Rad Laboratories, Inc.
|
186 | $54,610 | |
| 6 | GEHC |
GE HealthCare Technologies Inc.
|
528 | $33,796 | |
| 7 | GMED |
Globus Medical Inc
|
222 | $17,540 | |
| 8 | ZBH |
Zimmer Biomet Holdings, Inc.
|
89 | $7,661 |
All Filings in BSX
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,902 | 68 | Shares | Defined | 2026-07-23 | |
| 2025-12-31 | $9,344 | 98 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $6,736 | 69 | Shares | Sole | 2025-12-29 | |
| 2025-06-30 | $6,337 | 59 | Shares | Defined | 2025-08-19 | |
| 2025-03-31 | $2,522 | 25 | Shares | Sole | 2025-05-16 | |
| 2024-12-31 | $2,233 | 25 | Shares | Sole | 2025-02-05 | |
| 2023-12-31 | $3,699 | 64 | Shares | Sole | 2024-02-12 | |
| No filing history on record for this holder in this stock. | ||||||